{
  "image_filename": "figure_p3_det_2_002.png",
  "image_path": "Zimmerman_et_al.__2023_/extracted/figures/figure_p3_det_2_002.png",
  "image_type": "Figure",
  "page_number": 3,
  "block_id": "det_2_002",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "Flowchart showing the primary analysis cohorts with participant numbers for recombinant quadrivalent influenza vaccine (RIV4, n=3,047), standard dose influenza vaccine (SD-IIV4, n=862), and unvaccinated groups (n=8,878 for one cohort and n=1,398 for another), along with a note that 5,136 participants were included. does not support the claim because the image only presents participant group sizes and study cohort flow; it does not provide any information on antigenic matching with WHO- or FDA-selected strains. Note: The image is clear but contains only cohort allocation data, with no details on antigenic match or strain selection.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Flowchart showing the primary analysis cohorts with participant numbers for recombinant quadrivalent influenza vaccine (RIV4, n=3,047), standard dose influenza vaccine (SD-IIV4, n=862), and unvaccinated groups (n=8,878 for one cohort and n=1,398 for another), along with a note that 5,136 participants were included.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the image only presents participant group sizes and study cohort flow; it does not provide any information on antigenic matching with WHO- or FDA-selected strains.",
    "confidence_notes": "The image is clear but contains only cohort allocation data, with no details on antigenic match or strain selection."
  }
}